Neurocrine Biosciences
NBIX
#1366
Rank
ยฃ11.63 B
Marketcap
ยฃ116.66
Share price
0.84%
Change (1 day)
17.74%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2025 (TTM): ยฃ0.44 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are ยฃ2.68 Billion. In 2024 the company made an earning of ยฃ0.45 Billion, an increase over its 2023 earnings that were of ยฃ0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ0.44 B-3.92%
2024 ยฃ0.45 B96.41%
2023 ยฃ0.23 B41.13%
2022 ยฃ0.16 B73.74%
2021 ยฃ95.42 M-8.82%
2020 ยฃ0.10 B77.78%
2019 ยฃ58.86 M49.83%
2018 ยฃ39.28 M-142.57%
2017 -ยฃ92.29 Million-14.73%
2016 -ยฃ0.11 Billion53.15%
2015 -ยฃ70.67 Million46.25%
2014 -ยฃ48.32 Million29.66%
2013 -ยฃ37.27 Million-3530.8%
2012 ยฃ1.08 M-95.73%
2011 ยฃ25.44 M
2009 -ยฃ35.78 Million-45.38%
2008 -ยฃ65.49 Million-58.87%
2007 -ยฃ0.16 Billion87.3%
2006 -ยฃ85.01 Million351.97%
2005 -ยฃ18.81 Million-52.09%
2004 -ยฃ39.26 Million-10.98%
2003 -ยฃ44.11 Million
2001 -ยฃ32.92 Million
1999 -ยฃ14.85 Million108.32%
1998 -ยฃ7.13 Million
1996 ยฃ2.17 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Repligen
RGEN
ยฃ19.61 M-95.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
ยฃ1.18 B 171.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Palatin Technologies
PTN
-ยฃ12.98 Million-102.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ16.88 B 3,758.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ1.24 B 184.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ8.89 B 1,932.24%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
ยฃ37.92 M-91.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ31.33 Million-107.16%๐Ÿ‡บ๐Ÿ‡ธ USA